<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
INDV
Indivior
$
()


  • Indivior intends to facilitate U.S. primary listing, U.K. secondary listing

    4/25/2024 - 05:46am
  • Indivior reports Q1 adjusted EPS 37c, consensus 41c

    4/25/2024 - 05:42am
  • Indivior initiated with bullish view at Craig-Hallum, here's why

    4/3/2024 - 07:32am
  • Five new option listings and one option delisting on March 12th

    3/12/2024 - 08:30am
  • Indivior says OPVEE met primary endpoint in study

    3/11/2024 - 14:44pm
  • Indivior subsidiary receives final court approval for antitrust settlement

    2/29/2024 - 05:34am
  • Indivior management to meet virtually with Northland

    12/15/2023 - 08:25am
  • Indivior management to meet virtually with Northland

    12/15/2023 - 04:55am
  • Indivior management to meet virtually with Northland

    12/6/2023 - 15:04pm
  • Indivior settlement agreement lifts 'major overhang,' says Northland

    10/24/2023 - 09:30am
  • Indivior sees Q3 revenue $268M-$273M, one estimate $265M

    10/24/2023 - 09:08am
  • Indivior reaches agreement to resolve multi-district litigation

    10/24/2023 - 09:06am
  • Indivior upgraded to Buy from Hold at Liberum

    10/24/2023 - 05:11am
  • Fly Intel: After-Hours Movers

    10/11/2023 - 17:31pm
  • Indivior enters exclusive licensing agreement with Alar Pharmaceuticals

    10/11/2023 - 16:23pm
dynamic_feed Breaking News